Rezultati

eNauka >  Results >  Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE) : a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Title: Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE) : a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Authors Allen, Jeffrey A; ...; Basta, Ivana Z; ...; (broj, koautora 26)
Issue Date: 2024
Publication: LANCET NEUROLOGY
ISSN: 1474-4422 Lancet Neurology Search Idenfier
Type: Article
Collation: vol. 23 br. 10 str. 1013-1024
DOI: 10.1016/S1474-4422(24)00309-0
WoS-ID: 001319433700001
Scopus-ID: 2-s2.0-85203972760
URI: https://enauka.gov.rs/handle/123456789/940358
Project: Argenx
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

70
SCOPUSTM
65
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.